scPharmaceuticals (SCPH) PT Raised to $18 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts SCPH Hot Sheet
Price: $5.67 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on scPharmaceuticals (NASDAQ: SCPH) to $18.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
- Medtronic, Inc. (MDT) PT Lowered to $101 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
